Wednesday February 10 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

TESLASCAN Pages on BioPortfolio:

BioPortfolio - Teslascan
BioPortfolio's Approved Drugs Database. Teslascan. Mangafodipir Trisodium. Download PDF containing detailed information. PDF Version ...
http://www.bioportfolio.com/indepth/Teslascan.html...

BioPortfolio.com - BioWeb ALDACTAZIDE HYDROCHLOROTHIAZIDE ...
... November 1997 Original New Drug Applications Original Application #: 020652 Approval Date: 26-NOV-97 Trade Name: TESLASCAN Chemical Type: 1 Therapeutic ...
http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?DB=se...

BioPortfolio - Indepth Browse
... Genetics | Terra-Cortril | Terramycin | Teslac | Teslascan | Tessalon | Testicular | Testicular Cancer | Testicular Diseases | Testicular Disorders Male
...
http://www.bioportfolio.com/indepth/search/T.htm...

BioPortfolio's Approved Drugs News by Tradename - T to Th
TESLASCAN · TESSALON · TESTIM · TESTODERM · TESTOSTERONE · TESTRED · TESULOID · TETRACHEL · TETRACYCLINE ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

Results from other life science and pharmaceutical sites:

[Value of MRCP with Mangafodipir Trisodium (Teslascan) injection ...
RESULTS: MRCP with Teslascan injection demonstrated a bile leak in 20 patients. The site of leak was depicted in 17 cases: second order of smaller bile duct ...
http://www.ncbi.nlm.nih.gov/pubmed/18235349...

Mangafodipir - Wikipedia, the free encyclopedia
Mangafodipir (sold under the brand name Teslascan as mangafodipir trisodium) is a contrast agent delivered intravenously to enhance contrast in magnetic ...
http://en.wikipedia.org/wiki/Mangafodipir...

[Contribution of MR cholangiography after Teslascan infusion for ...
[Contribution of MR cholangiography after Teslascan infusion for the diagnosis of post-traumatic biliary injury]. [Article in French] ...
http://www.ncbi.nlm.nih.gov/pubmed/15041819...

NOTICE OF FINAL DETERMINATION
product TESLASCAN®, is eligible for patent term extension under 35 U.S.C. § 156. ... TESLASCAN®. Term Extended. : 1765 days. Expiration Date of Extension : ...
http://www.uspto.gov/web/offices/com/sol/foia/comm/pte/49334...

Detection of bile duct leaks using MR cholangiography with ...
Mangafodipir trisodium (Teslascan), a hepatobiliary contrast agent, has the potential of providing functional biliary imaging similar to hepatobiliary ...
http://www.ncbi.nlm.nih.gov/pubmed/11176303...

Clinical Study: 03-N-0142, Development of 7 Tesla MRI Methodology ...
Participants will have a standard 1.5 or 3 Tesla MRI before the 7 Tesla scan, adding about 5 minutes to the procedure. The procedure for both scans is the ...
http://clinicalstudies.info.nih.gov/detail/A_2003-N-0142.htm...

Using contrast-enhanced MR cholangiography with IV mangafodipir ...
Using contrast-enhanced MR cholangiography with IV mangafodipir trisodium ( Teslascan) to evaluate bile duct leaks after cholecystectomy: a prospective
study ...
http://www.ncbi.nlm.nih.gov/pubmed/12130442...

Table of Contents: January 31, 2000
31 Jan 2000 ... 4614-4615 Human drugs: Patent extension; regulatory review period determinations-- Teslascan, 4615-4616 Medical devices: Patent ...
http://www.epa.gov/fedrgstr/EPAFR-CONTENTS/2000/January/Day-...

Magnetic resonance cholangiography with mangafodipir trisodium ...
Magnetic resonance cholangiography with mangafodipir trisodium (Teslascan) to evaluate bile duct leaks after T-tube removal in liver transplantation. ...
http://www.ncbi.nlm.nih.gov/pubmed/15480033...

Questions and Answers on Gadolinium-Based Contrast Agents
1 Sep 2009 ... However, the two other approved MRI contrast agents, Feridex, I.V. (an iron- containing injectable solution) and Teslascan (a ...
http://www.fda.gov/Drugs/DrugSafety/DrugSafetyNewsletter/ucm...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.